Optimal allocation to treatments in a sequential multiple assignment randomized trial

Publication date

2021-11

Authors

Morciano, Andrea
Moerbeek, MirjamISNI 0000000388211488

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

One of the main questions in the design of a trial is how many subjects should be assigned to each treatment condition. Previous research has shown that equal randomization is not necessarily the best choice. We study the optimal allocation for a novel trial design, the sequential multiple assignment randomized trial, where subjects receive a sequence of treatments across various stages. A subject's randomization probabilities to treatments in the next stage depend on whether he or she responded to treatment in the current stage. We consider a prototypical sequential multiple assignment randomized trial design with two stages. Within such a design, many pairwise comparisons of treatment sequences can be made, and a multiple-objective optimal design strategy is proposed to consider all such comparisons simultaneously. The optimal design is sought under either a fixed total sample size or a fixed budget. A Shiny App is made available to find the optimal allocations and to evaluate the efficiency of competing designs. As the optimal design depends on the response rates to first-stage treatments, maximin optimal design methodology is used to find robust optimal designs. The proposed methodology is illustrated using a sequential multiple assignment randomized trial example on weight loss management.

Keywords

cost constraint, efficiency, maximin designs, optimal allocation, response rates, sequential multiple assignment randomized trial trials, Epidemiology, Statistics and Probability, Health Information Management

Citation

Morciano, A & Moerbeek, M 2021, 'Optimal allocation to treatments in a sequential multiple assignment randomized trial', Statistical Methods in Medical Research, vol. 30, no. 11, pp. 2471-2484. https://doi.org/10.1177/09622802211037066